Coombes lab begins research collaboration with Qu Biologics

Vancouver, British Columbia - Qu Biologics Inc. is a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to stimulate the body’s immune system against autoimmune diseases and cancer. The Coombes lab is pleased to be working with Qu Biologics to study a new Crohn’s disease research model. The partnership was recently featured in BioTechnology Focus.